173039-05-9

Basic information

• Product Name: Pentanedioic acid, 2-methylene-, bis(phenylmethyl) ester
• Synonyms: dibenzyl 2-Methylenepentanedioate;dibenzyl 2-methylenepentane-1,5-dioate;dibenzyl 2-methyleneglutarate;2-methylenepentanedioic acid dibenzyl ester
• CAS NO: 173039-05-9
• Molecular Formula: C20H20O4
• Molecular Weight: 324.376
• Mol File: 173039-05-9.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 424.1±30.0 °C(Predicted)
• Density: 1.142±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Pentanedioic acid, 2-methylene-, bis(phenylmethyl) ester(CAS DataBase Reference)
• NIST Chemistry Reference: Pentanedioic acid, 2-methylene-, bis(phenylmethyl) ester(173039-05-9)
• EPA Substance Registry System: Pentanedioic acid, 2-methylene-, bis(phenylmethyl) ester(173039-05-9)

Safety Data

• Hazardous Substances Data: 173039-05-9(Hazardous Substances Data)

Upstream product

• 56977-08-3 glutaric acid dibenzyl ester 
• 2495-35-4 benzylacrylate 

Downstream Products

• 200698-33-5 2,4-di(benzyloxycarbonyl)-butyl(4-methylbenzyl)-o-benzylphosphinic acid 
• 173039-06-0 dibenzyl 2-[[bis(benzyloxy)phosphoryl]methyl]-pentanedioate 
• 200698-34-6 2,4-di(benzyloxycarbonyl)butylphosphinic acid 
• 200698-29-9 Benzyl[2,4-di(benzyloxycarbonyl)butyl]phosphinic acid 
• 200698-31-3 2,4-Di(benzyloxycarbonyl)butyl(3-phenylpropyl)-phosphinic acid 
• 200698-30-2 2,4-di(benzyloxycarbonyl)-butyl(phenethyl)phosphinic acid 
• 926621-98-9 2-[(3-tert-butoxycarbonylamino-propyl)-hydroxy-phosphinoylmethyl]-pentanedioic acid dibenzyl ester 
• 173039-10-6 2-(phosphonomethyl)pentanedioic acid 
• 263393-92-6 5-[Benzyloxy-(2,4-bis-benzyloxycarbonyl-butyl)-phosphinoyl]-4-benzyloxycarbonyl-pentanoic acid benzyl ester 
• 263393-90-4 4,8-bis-benzyloxycarbonyl-6-oxo-undecanedioic acid dibenzyl ester 
• 263393-89-1 4-benzyloxycarbonyl-6-nitro-nonanedioic acid dibenzyl ester 

Relevant articles and documents

Diagnostic device for the detection of disease related target structures

The present invention provides a diagnostic device allowing highly specific and efficient in vivo and/or in vitro detection of a bio marker in a broad range of bodily fluids or tissues. The diagnostic device is composed of a binding agent that specificall

DENDRIMER BASED COMPOSITIONS AND METHODS OF USING THE SAME

The present invention relates to novel therapeutic and diagnostic dendrimers. In particular, the present invention is directed to dendrimer based compositions and systems for use in disease diagnosis and therapy (e.g., cancer diagnosis and therapy). The compositions and systems comprise one or more components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and monitoring the response to therapy of a cell or tissue (e.g., a tumor).

Dendrimer based compositions and methods of using the same

The present invention relates to novel therapeutic and diagnostic dendrimers. In particular, the present invention is directed to dendrimer based compositions and systems for use in disease diagnosis and therapy (e.g., cancer diagnosis and therapy). The c